Expression of Cathepsin D in early-stage breast cancer and its prognostic and predictive value
Breast Cancer Research and Treatment · 2024
DOI: 10.1007/s10549-024-07293-y ↗Kurz gefasst
Fachartikel in der Zeitschrift Breast Cancer Research and Treatment, 2024. Verfasst von Inas Alhudiri und 5 weiteren Autor:innen. Beteiligte Einrichtung: Breast Pathology Research Group, Nottingham Breast Cancer Research Centre, Biodiscovery Institute, Faculty of Medicine, The University of Nottingham,…. Hauptthemen laut MEDLINE: Cathepsin D, Breast Neoplasms, Biomarkers, Tumor, Neoplasm Staging. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
Cathepsin D is a proteolytic enzyme that is normally localized in the lysosomes and is involved in the malignant progression of breast cancer. There are conflicting results regarding Cathepsin D significance as prognostic and predictor marker in breast cancer. This study aimed to evaluate the expression and prognostic significance of Cathepsin D in early-stage breast cancer.
Methods
Expression of Cathepsin D was assessed by immunohistochemical staining of tissue microarrays, in a large well-characterized series of early-stage operable breast cancer ( n = 954) from Nottingham Primary Breast Carcinoma Series between the period of 1988 and 1998 who underwent primary surgery. Correlation of Cathepsin D expression with clinicopathological parameters and prognosis was evaluated.
Results
Cathepsin D expression was positive in 71.2% (679/954) of breast cancer tumours. Positive expression of Cathepsin D was significantly associated with high histological grade ( p = 0.007), pleomorphism ( p = 0.002), poor Nottingham Prognostic Index (NPI) score ( p < 0.002), recurrence ( p = 0.005 ) and distant metastasis ( p < 0.0001). Kaplan–Meier analysis showed that Cathepsin D expression was significantly associated with shorter breast cancer-specific survival ( p = 0.001), higher risk of recurrence ( p = 0.001) and distant metastasis ( p < 0.0001). ER-positive tumours expressing Cathepsin D and treated with tamoxifen demonstrated a significantly higher risk of distant metastasis.
Conclusion
Cathepsin D expression significantly predicts poor prognosis in breast cancer and is associated with variables of poor prognosis and shorter outcome. The strong association of Cathepsin D with aggressive tumour characteristics and poor outcomes warrants further research of its potential as a therapeutic target The results also suggest a possible interaction between Cathepsin D and tamoxifen therapy in ER-positive breast cancer which needs further investigation to elucidate the underlying mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Breast Pathology Research Group, Nottingham Breast Cancer Research Centre, Biodiscovery Institute, Faculty of Medicine, The University of Nottingham, Nottingham, UK.
- Genetic Engineering Department, Libyan Biotechnology Research Centre, Tripoli, Libya.
- Breast Pathology Research Group, Nottingham Breast Cancer Research Centre, Biodiscovery Institute, Faculty of Medicine, The University of Nottingham, Nottingham, UK. andrew.green@nottingham.ac.uk.
- Eastern Bowel Cancer Screening Hub, Nottingham University Hospitals, NHS Trust, Nottingham, UK.
Zitieren
APA
Alhudiri, I., Nolan, C., Ellis, I., Elzagheid, A., Green, A., & Chapman, C. (2024). Expression of Cathepsin D in early-stage breast cancer and its prognostic and predictive value. Breast Cancer Research and Treatment. https://doi.org/10.1007/s10549-024-07293-y
Vancouver
Alhudiri I, Nolan C, Ellis I, Elzagheid A, Green A, Chapman C. Expression of Cathepsin D in early-stage breast cancer and its prognostic and predictive value. Breast Cancer Research and Treatment. 2024. doi:10.1007/s10549-024-07293-y
BibTeX
@article{Alhudiri2024,
author = {Alhudiri, Inas and Nolan, Christopher and Ellis, Ian and Elzagheid, Adam and Green, Andrew and Chapman, Caroline},
title = {Expression of Cathepsin D in early-stage breast cancer and its prognostic and predictive value},
journal = {Breast Cancer Research and Treatment},
year = {2024},
doi = {10.1007/s10549-024-07293-y}
}
EUVIMED